Having failed to cure cancer, almost out of cash ValiRx (VAL) needs another story to ramp to allow its low-life brokers Peterhouse to get another discounted placing away to its spivvy flipper mates. Ahoy is that a bandwagon I see in the distance? Yes it is the Covid Express. Time to jump aboard.
Here we go again. Grace Slick could have been thinking of Peterhouse’s antics – as exposed here - when penning her most famous number “When logic and proportion, Have fallen sloppy dead” Exactly. So what is the ValiRx (VAL) white rabbit?
A bit of a storm has been blowing up at AIM-listed cash-hungry biotech dog ValiRx (VAL). A General Meeting had been proposed for shareholders to agree to the issue of yet more confetti in order to keep the Grim Reaper from the door but the government decreed Covid-19 lockdown intervened and the meeting could not happen. Yesterday the GM was reconvened with shareholders unable to attend or vote – and two of the three resolutions were passed. But what of legality?...
When I first commented on AIM-listed cancer drug developer ValiRx (VAL) back in 2016 the shares had just seen a pump’n’dump which pushed the stock up to 21p before a placing at just 12p. Now the stock is just 0.1p and on a market cap of £0.9m (source: ADVFN): never mind the 90% club, this is a fully paid up member of the 99% club. And now we have a placing for just £200,000 gross…..and Broker number three joins the fray, although as Tom Winnifrith points out the RNS will have to be reissued.How on earth can you justify paying three broker retainers for a company worth less than a million pounds?
I do not wish to be seen as a pedant but an RNS statement is meant to be, you know, like, er, accurate. And thus as an upstanding member of the AIM Casino community I have penned a quick email to my pal Liam Murray at Nomad Cairn Financial about today's RNS from ValirX (VAL) which appears to fail the accuracy test. I write.